Strengthening the use of artificial intelligence within healthcare delivery organizations: balancing regulatory compliance and patient safety.
PMID: 38767890 ·
M, a, r, k, , P, , S, e, n, d, a, k, ;, , V, i, n, c, e, n, t, , X, , L, i, u, ;, , A, s, h, l, e, y, , B, e, e, c, y, ;, , D, a, v, i, d, , E, , V, i, d, a, l, ;, , K, e, o, , S, h, a, w, ;, , M, a, r, k, , A, , L, i, f, s, o, n, ;, , D, a, n, n, y, , T, o, b, e, y, ;, , A, l, e, x, a, n, d, r, a, , V, a, l, l, a, d, a, r, e, s, ;, , B, r, e, n, n, a, , L, o, u, f, e, k, ;, , M, u, r, t, a, z, a, , M, o, g, r, i, ;, , S, u, r, e, s, h, , B, a, l, u
Publicidad
Resumen
Surface the urgent dilemma that healthcare delivery organizations (HDOs) face navigating the US Food and Drug Administration (FDA) final guidance on the use of clinical decision support (CDS) software. We use sepsis as a case study to highlight the patient safety and regulatory compliance tradeoffs that 6129 hospitals in the United States must navigate. Sepsis CDS remains in broad, routine use. There is no commercially available sepsis CDS system that is FDA cleared as a medical device. There is
Publicidad
Fuente oficial
Ver en PubMed →Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.